Page 900 - Read Online

Galvez et al. Mini-invasive Surg 2020;4:86 I http://dx.doi.org/10.20517/2574-1225.2020.86 Page 11 of 12

REFERENCES
1. Press release no 263. International Agency for Research on Cancer. World Health Organization (WHO) 2018. Available from: https://
www.who.int/ionizing_radiation/research/iarc/en/. [Last accessed on 23 Nov 2020]
2. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in
the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51.
3. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac
Surg 1995;60:615-22
4. Bao F, Ye P, Yang Y, et al. Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis. Eur J Cardio-thoracic Surg
2014;46:1-7.
5. Dziedzic R, Zurek W, Marjański T, et al. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection
from the polish national lung cancer registry. Eur J Cardio-thoracic Surg 2017;52:363-9.
6. Song CY, Sakai T, Kimura D, Tsushima T, Fukuda I. Comparison of perioperative and oncological outcomes between video-assisted
segmentectomy and lobectomy for patients with clinical stage IA non-small cell lung cancer: a propensity score matching study. J Thorac
Dis 2018;10:4891-901.
7. Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann
Thorac Surg 2018;105:1483-91.
8. Moon MH, Moon YK, Moon SW. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: a
population-based study. Respirology 2018;23:695-703.
9. Ackerson BG, Tong BC, Hong JC, et al. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. Lung Cancer
2018;125:185-91.
10. Hiraki T, Gobara H, Mimura H, Matsui Y, Toyooka S, Kanazawa S. Percutaneous radiofrequency ablation of clinical stage I non-small
cell lung cancer. J Thorac Cardiovasc Surg 2011;142:24-30.
11. Nagata Y, Hiraoka M, Shibata T, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0
non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys 2015;93:989-96.
12. Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung
cancer: a comprehensive review. Cancer 2018;124:667-78.
13. Nyman J, Hallqvist A, Lund JÅ, et al. SPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically
inoperable stage I NSCLC. Radiother Oncol 2016;121:1-8.
14. Li C, Wang L, Wu Q, et al. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I
non-small cell lung cancer. Medicine (Baltimore) 2020;99:e21715.
15. Falkson CB, Vella ET, Yu E, et al. Radiotherapy with curative intent in patients with early-stage, medically inoperable, non-small-cell
lung cancer: a systematic review. Clin Lung Cancer 2017;18:105-21.e5.
16. Varlotto J, Fakiris A, Flickinger J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage i non-
small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013;119:2683-91.
17. Timmerman RD, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer patients.
JAMA 2010;303:1070-6.
18. Harris AA, Stang K, Small C, et al. Pretreatment factors influencing radiation pneumonitis after stereotactic body radiation therapy in the
treatment of lung cancer. Cureus 2020;12.
19. Morias S, Marcu LG, Short M, et al. Treatment-related adverse effects in lung cancer patients after stereotactic ablative radiation therapy.
J Oncol 2018;2018:6483626.
20. Wink KCJ, van Baardwijk A, Troost EGC, De Ruysscher D. Nodal recurrence after stereotactic body radiotherapy for early stage non-
small cell lung cancer: incidence and proposed risk factors. Cancer Treat Rev 2017;56:8-15.
21. Altorki NK, Kamel MK, Narula N, et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for
patients with small cT1N0 non-small cell lung cancer. J Thorac Oncol 2016;11:1984-92.
22. Gossot D, Lutz J, Grigoroiu M, Brian E, Seguin-Givelet A. Thoracoscopic anatomic segmentectomies for lung cancer: technical aspects.
J Vis Surg 2016;2:171.
23. Guo Z, Yin W, Pan H, et al. Video-assisted thoracoscopic surgery segmentectomy by non- intubated or intubated anesthesia : a
comparative analysis of short-term outcome. J Thorac Dis 2016;8:359-68.
24. Hung MH, Hsu HH, Chan KC, et al. Non-intubated thoracoscopic surgery using internal intercostal nerve block, vagal block and targeted
sedation. Eur J Cardiothorac Surg 2014;46:620-5.
25. Charloux A, Quoix E. Lung segmentectomy: does it offer a real functional benefit over lobectomy? Eur Respir Rev 2017;26:170079.
26. Traibi A, Grigoroiu M, Boulitrop C, et al. Predictive factors for complications of anatomical pulmonary segmentectomies. Interact
Cardiovasc Thorac Surg 2013;17:838-44.
27. Ettinger DS, Wood DE, Aggarwal C. NCCN clinical practice guidelines in oncology (NCCN Guidelines®) guideline non-small cell lung
cancer version 7. 2019. Available from: https://jnccn.org/view/journals/jnccn/17/12/article-p1464.xml?print&print&print. [Last accessed
on 3 Dec 2020]
28. Vansteenkiste J, Crino L, Dooms C, et al. 2nd ESMO consensus conference on lung cancer: early stage non-small cell lung cancer
consensus on diagnosis, treatment and follow-up. Ann Oncol 2014;25:1462-74.
29. Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-
small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2009;40:271-4.